Patents Assigned to Digibio
  • Patent number: 9421225
    Abstract: The invention concerns a method and a system for producing a signal, in particular an electric signal, or a substance having a coagulating or anticoagulant effect. The method is characterized in that it is based on a source substance with coagulating effect, in particular, Ca++ ions, or an anticoagulant affect, in particular heparin. The method consists in: transforming the electromagnetic field derived from said source substance located in the chamber, into a signal, in particular an electric signal, using a transducer-receiver sensing the electromagnetic field; applying to a receiving substance located in the chamber, in particular water or a water-ethanol mixture or homeopathic granules, said signal derived from said transducer-receiver, using a transducer-transmitter. After said treatment, the receiving substance, initially inactive, has a coagulating or anticoagulant effect.
    Type: Grant
    Filed: December 8, 2009
    Date of Patent: August 23, 2016
    Assignee: DiGiBio
    Inventors: Jacques Benveniste, Didier Guillonnet
  • Publication number: 20100272629
    Abstract: The invention relates to a method and a system for giving a substance (101) receptive and/or transmissive properties that allow the substance (101) to be treated by and/or to transmit a signal acquired by intercepting an electromagnetic field originating from a source substance. The substance (101) is subjected, by means of a transmitter (102), to an electromagnetic field and/or a sound (104) emitted at one or more frequencies included in a predetermined frequency spectrum for a predetermined period. The invention makes it possible to give the initially non-receptive and non-transmissive substance (101)y receptive and/or transmissive properties.
    Type: Application
    Filed: June 1, 2005
    Publication date: October 28, 2010
    Applicant: DIGIBIO SA
    Inventors: Jacques Benveniste, Jerome Benveniste, Vincent Benveniste, Laurent Benveniste, Claire Benveniste, Alice Benveniste
  • Publication number: 20100233296
    Abstract: The invention concerns a method and a system for producing a signal, in particular an electric signal, or a substance having a coagulating or anticoagulant effect. The method is characterised in that it is based on a source substance with coagulating effect, in particular, Ca++ ions, or an anticoagulant affect, in particular heparin. The method consists in: transforming the electromagnetic field derived from said source substance located in the chamber, into a signal, in particular an electric signal, using a transducer-receiver sensing the electromagnetic field; applying to a receiving substance located in the chamber, in particular water or a water-ethanol mixture or homeopathic granules, said signal derived from said transducer-receiver, using a transducer-transmitter. After said treatment, the receiving substance, initially inactive, has a coagulating or anticoagulant effect.
    Type: Application
    Filed: December 8, 2009
    Publication date: September 16, 2010
    Applicant: DigiBio
    Inventors: Jacques Benveniste, Laurent Benveniste, Didier Guillonnet
  • Patent number: 6541978
    Abstract: The invention concerns a method, a system and a device for producing, from a substance, electric signals characteristic of the biological activity of an active element contained in the substance. The method consists in: placing the substance in a zone subjected to a specific electric, magnetic and/or electromagnetic excitation field. The method further includes a step which consists in transforming the fields resulting form the interaction between the specific excitation filed and the substance, into signals, in particular electric signals, using a first transducer receiving the resulting fields.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: April 1, 2003
    Assignee: Digibio
    Inventors: Jacques Benveniste, Didier Guillonnet